Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The nature of Asian biopharmaceutical innovation

Nature Biotechnology volume 32, pages 523–524 (2014)Cite this article

Subjects

To the Editor:

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Figure 1

References

  1. Jelinek, M. et al. Res. Technol. Manag. 55, 16–6 (2012).

    Article  Google Scholar 

  2. Code of Federal Regulations, Title 21 C.F.R. § 314.53.

  3. Friedman, Y. Nat. Rev. Drug Discov. 9, 835–836 (2010).

    CAS  Article  Google Scholar 

  4. Light, D.W. Health Aff. 28, w969–w977 (2009).

    Article  Google Scholar 

  5. Pharmaceutical Research and Manufacturers of America, Pharmaceutical Industry Profile 2012. http://www.phrma.org/sites/default/files/159/phrma_industry_profile.pdf (PhRMA; Washington, DC, April 2012)

  6. Locke, R.M. & Wellhausen, R. A Preview of the MIT Production in the Innovation Economy Report. http://web.mit.edu/pie/news/PIE_Preview.pdf (Massachusetts Institute of Technology, Cambridge, MA, 2013).

    Google Scholar 

  7. Breznitz, D. & Murphree, M. Run of the Red Queen Government, Innovation, Globalization, and Economic Growth in China (Yale University Press, New Haven CT, 2011)

    Google Scholar 

  8. National Science Board. Science and Engineering Indicators 2012. NSB 12–01 (National Science Foundation, Washington, DC, 2012)

  9. World Intellectual Property Organization. 2012 World Intellectual Property Indicators (WIPO, Geneva, Switzerland, December 2012)

Download references

Author information

Affiliations

  1. DrugPatentWatch.com and Thinkbiotech, Washington, DC, USA

    Yali Friedman

Authors
  1. Yali Friedman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yali Friedman.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Friedman, Y. The nature of Asian biopharmaceutical innovation. Nat Biotechnol 32, 523–524 (2014). https://doi.org/10.1038/nbt.2933

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2933

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing